Int J Med Sci 2022; 19(3):484-485. doi:10.7150/ijms.71620 This issue Cite

Erratum

CD8+ T cell survival in lethal fungal sepsis was ameliorated by T-cell-specific mTOR deletion: Erratum

Hao Wang1*, Wen Han1*, Ran Guo1, Guangxu Bai1, Jianwei Chen1, Na Cui1,2✉

1. Department of Critical Care Medicine, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Science, Beijing 100730, China.
2. Department of Clinical Laboratory, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Science; Beijing Key Laboratory for Mechanisms Research and Precision Diagnosis of Invasive Fungal Diseases, Beijing 100730, China.
*These authors contributed equally to this work.

Citation:
Wang H, Han W, Guo R, Bai G, Chen J, Cui N. CD8+ T cell survival in lethal fungal sepsis was ameliorated by T-cell-specific mTOR deletion: Erratum. Int J Med Sci 2022; 19(3):484-485. doi:10.7150/ijms.71620. https://www.medsci.org/v19p0484.htm
Other styles

File import instruction

Corrected-article in Int J Med Sci, Volume 18, 3004


Citation styles

APA
Wang, H., Han, W., Guo, R., Bai, G., Chen, J., Cui, N. (2022). CD8+ T cell survival in lethal fungal sepsis was ameliorated by T-cell-specific mTOR deletion: Erratum. International Journal of Medical Sciences, 19(3), 484-485. https://doi.org/10.7150/ijms.71620.

ACS
Wang, H.; Han, W.; Guo, R.; Bai, G.; Chen, J.; Cui, N. CD8+ T cell survival in lethal fungal sepsis was ameliorated by T-cell-specific mTOR deletion: Erratum. Int. J. Med. Sci. 2022, 19 (3), 484-485. DOI: 10.7150/ijms.71620.

NLM
Wang H, Han W, Guo R, Bai G, Chen J, Cui N. CD8+ T cell survival in lethal fungal sepsis was ameliorated by T-cell-specific mTOR deletion: Erratum. Int J Med Sci 2022; 19(3):484-485. doi:10.7150/ijms.71620. https://www.medsci.org/v19p0484.htm

CSE
Wang H, Han W, Guo R, Bai G, Chen J, Cui N. 2022. CD8+ T cell survival in lethal fungal sepsis was ameliorated by T-cell-specific mTOR deletion: Erratum. Int J Med Sci. 19(3):484-485.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.